Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Lenhard

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|March 8, 2011
Lipogenic enzymes as therapeutic targets for obesity and diabetesJames M Lenhard
The Journal of Biological Chemistry|April 9, 2002
Select HIV protease inhibitors alter bone and fat metabolism ex vivoRenu G Jain, James M Lenhard
Advanced Drug Delivery Reviews|October 24, 2002
Preclinical developments in type 2 diabetesJames M Lenhard, William K Gottschalk
Biochemical and Biophysical Research Communications|October 7, 2004
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatmentsJames M Lenhard, Dallas K Croom, Dana T Minnick
Pharmacogenetics and Genomics|November 3, 2015
A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitusQingqin S Li, James M Lenhard, Yiping Zhan, et al.
Redox Biology|March 14, 2014
Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brainMoshe Cohen-Kutner, Lena Khomsky, Michael Trus, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 29, 2019
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese miceKamal Albarazanji, Matthew Jennis, Cassandre R Cavanaugh, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 4, 2020
Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic ControlEmily C Soriano, James M Lenhard, Jeffrey S Gonzalez, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|March 8, 2011
Lipogenic enzymes as therapeutic targets for obesity and diabetesJames M Lenhard
The Journal of Biological Chemistry|April 9, 2002
Select HIV protease inhibitors alter bone and fat metabolism ex vivoRenu G Jain, James M Lenhard
Advanced Drug Delivery Reviews|October 24, 2002
Preclinical developments in type 2 diabetesJames M Lenhard, William K Gottschalk
Biochemical and Biophysical Research Communications|October 7, 2004
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatmentsJames M Lenhard, Dallas K Croom, Dana T Minnick
Pharmacogenetics and Genomics|November 3, 2015
A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitusQingqin S Li, James M Lenhard, Yiping Zhan, et al.
Redox Biology|March 14, 2014
Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brainMoshe Cohen-Kutner, Lena Khomsky, Michael Trus, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 29, 2019
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese miceKamal Albarazanji, Matthew Jennis, Cassandre R Cavanaugh, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 4, 2020
Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic ControlEmily C Soriano, James M Lenhard, Jeffrey S Gonzalez, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Pageof 2